Loading company…
Notify Therapeutics develops treatments for female infertility, including therapies targeting diminished ovarian reserve.
Notify Therapeutics is developing a non-hormonal treatment for women with diminished ovarian reserves who respond poorly to standard hormone therapies. Its approach uses compounds that stimulate the NRF2 pathway to activate dormant ovarian follicles. Founded in 2021 by Karin Lykke-Hartmann, the company is based in Copenhagen, Denmark, and is at the Series A stage. In September 2023, it raised EUR 5 million from +ND Capital and Lundbeck Foundation.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in